Documentation Centre

Flash required
November 05, 2010
Do you think that CB1 antagonists need to have a CNS-mediated effect in order to help us manage high-risk abdominally obese patients?
By Vincenzo Di Marzo, PhD, Istituto di Chimica Biomolecolare Pozzuoli, NA, Italy [0:37 min.] [3MB]

  • See all Expert Opinions of Vincenzo Di Marzo, PhD, Istituto di Chimica Biomolecolare Pozzuoli, NA, Italy

Download Video


Key Words
Abdominal Obesity/Body Fat Distribution, Metabolism: Animal Studies